Viewing Study NCT01149850


Ignite Creation Date: 2025-12-24 @ 4:49 PM
Ignite Modification Date: 2025-12-27 @ 3:29 AM
Study NCT ID: NCT01149850
Status: COMPLETED
Last Update Posted: 2024-09-19
First Post: 2010-06-22
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Bevacizumab and Temozolomide in Treating Older Patients With Newly-Diagnosed Glioblastoma Multiforme or Gliosarcoma
Sponsor: Jonsson Comprehensive Cancer Center
Organization:

Organization Data

Organization:
Class: OTHER
Study ID: 10-000760
Study Type: None
Study Domain: None
Study Link: None
Lead Sponsor:
Lead Sponsor Class: OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type: SPONSOR
Responsible Party Affiliation:
Old Name: None
Old Organization: None

Collaborators

Collaborators

Name Class View
None INDUSTRY View